000 01160 a2200325 4500
005 20250517221630.0
264 0 _c20190517
008 201905s 0 0 eng d
022 _a1879-016X
024 7 _a10.1016/j.pharmthera.2018.05.014
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWei, Min
245 0 0 _aTargeting phosphatases of regenerating liver (PRLs) in cancer.
_h[electronic resource]
260 _bPharmacology & therapeutics
_c10 2018
300 _a128-138 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aDisease Progression
650 0 4 _aDrug Development
_xmethods
650 0 4 _aHumans
650 0 4 _aMolecular Targeted Therapy
650 0 4 _aNeoplasm Staging
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aProtein Tyrosine Phosphatases
_xantagonists & inhibitors
700 1 _aKorotkov, Konstantin V
700 1 _aBlackburn, Jessica S
773 0 _tPharmacology & therapeutics
_gvol. 190
_gp. 128-138
856 4 0 _uhttps://doi.org/10.1016/j.pharmthera.2018.05.014
_zAvailable from publisher's website
999 _c28487772
_d28487772